Paris,  January 26, 2015 - NEOVACS (Alternext Paris : ALNEV), a leader in active immunotherapies for
the treatment of autoimmune diseases, annonced today its financial reporting calendar for 2015.


Financial publications will be released prior to the opening of the Paris stock exchange. This calendar is
indicative and subject to change.

  • 2014 Full-Year Results                         February 27, 2015
  • Shareholders' AGM                             April 8, 2015
  • Half-Year results                                  September 4, 2015



distributed by